2024    2023    2022    2021    2020    2019    2018    2017    2016   

2015

Articles

71 - 

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP)

Emmanuelle Le Page, David Veillard, David A Laplaud, Stéphanie Hamonic, Rasha Wardi et al.

The Lancet, 2015, 386 (9997), pp.974-981.

DOI : https://doi.org/10.1016/S0140-6736(15)61137-0

Pubmed : 26135706

 

72 - 

Switching from initial first-line agents to other disease modifying therapies: an observational study

Emmanuelle Le Page, Véronique Deburghgraeve, Anne Kerbrat, Gilles Edan

Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.601--602.

 

73 - 

Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study.

Emmanuelle Le Page, Véronique Deburghgraeve, Marie-Antoinette Lester, Isabelle Cardiet, Emmanuelle Leray et al.

Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study. Journal of Neurology, 2015, 262 (4), pp.1024-1034.

DOI : https://doi.org/10.1007/s00415-015-7653-3

Pubmed : 25701008

 

74 - 

Non-invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis.

Ludivine Legros, Edouard Bardou-Jacquet, Marianne Latournerie, Anne Guillygomarc'H, Bruno Turlin et al.

Non-invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis. Liver International, 2015, 35 (6), pp.1731-1738.

DOI : https://doi.org/10.1111/liv.12762

Pubmed : 25495562

 

75 - 

Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells

Florian Lemaitre, Benoit Blanchet, Marianne Latournerie, Marie Antignac, Pauline Houssel-Debry et al.

Clinical Biochemistry, 2015, 48 (6), pp.406-411.

DOI : https://doi.org/10.1016/j.clinbiochem.2014.12.018

Pubmed : 25562187

 

76 - 

Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood

Florian Lemaitre, Nesrine Hasni, Pascal Leprince, Emmanuel Corvol, Ghassen Belhabib et al.

Critical Care, 2015, 19 (1), pp.40.

DOI : https://doi.org/10.1186/s13054-015-0772-5

Pubmed : 25886890

 

77 - 

Lack of drug interaction between cyclosporine and telaprevir in a liver transplant recipient

F. Lemaître, C. Jézéquel, M.-C. Verdier, M. Dermu, C. Boglione-Kerrien et al.

Transplant Infectious Disease, 2015, 17 (1), pp.106--110.

DOI : https://doi.org/10.1111/tid.12335

Pubmed : 25573697

 

78 - 

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study

Emmanuelle Leray, Sandra Vukusic, Marc Debouverie, Michel Clanet, Bruno Brochet et al.

PLoS ONE, 2015, 10 (7), pp.1-12.

DOI : https://doi.org/10.1371/journal.pone.0132033

Pubmed : 26148099

 

79 - 

Efficacy of Sofosbuvir and Daclatasvir in Patients with Fibrosing Cholestatic Hepatitis C After Liver Transplantation

Vincent Leroy, Jérôme Dumortier, Audrey Coilly, Mylène Sebagh, Claire Fougerou-Leurent et al.

Clinical Gastroenterology and Hepatology, 2015, 13 (11), pp.1993-2001.e2.

DOI : https://doi.org/10.1016/j.cgh.2015.05.030

Pubmed : 26044317

 

80 - 

Is home blood pressure monitoring feasible and well accepted in nephrectomized patients for renal cancer? (STAFF study).

Nolwenn Lorcy, Caroline Dourmap-Collas, Alexandre Lafourcade, Sylvie Le Stum, Brigitte Victor et al.

Is home blood pressure monitoring feasible and well accepted in nephrectomized patients for renal cancer? (STAFF study). Blood Pressure, 2015, 24 (2), pp.86-89.

DOI : https://doi.org/10.3109/08037051.2014.986932

Pubmed : 25531211